Focused on gynecologic oncology.
Built around real‑world conversation.
Oncology Out Loud is an independent clinical insights agency specializing in gynecologic oncology. Clinicians speak candidly with peers while industry partners silently observe an unfiltered discussion.
Perspectives from across the gynecologic oncology ecosystem
University-based
Community-based
Gynecologic oncologists
Medical oncologists
Advanced practice providers
Why Oncology Out Loud
Four reasons we’re different
Scope
Exclusive focus on gynecologic oncology
Ovarian, endometrial, and cervical cancers each have their own evidence base and unresolved questions. We work across all of them, and nothing else.
Reach
Beyond the familiar faces
Our established network reaches the community clinicians who routinely manage gynecologic cancers, not just the most visible academic experts.
Independence
Independent by design
Content is unbranded and balanced, led by a practicing gynecologic oncology expert chair who also moderates. OOL manages recruitment and logistics. Industry partners remain hands-off and silent throughout.
Experience
We’ve been on both sides
Our team has worked on both sides: launching medicines in industry, and running insights programs at agencies. We turn blinded clinical insight into strategic implications, not just summaries.
What we deliver
Programs designed for specific clinical conversations
Each is chair-led and includes around a dozen clinicians, run in a series across select regions, in-person or virtually.
Treatment landscape insights
How oncologists are managing gynecologic cancers today.
See how it works →
Care team practices
How the broader care team approaches complex cases.
See how it works →
Congress data implications
How clinicians perceive breaking data from major congresses.
See how it works →
Views on regional trials
What clinicians know about regionally available clinical trials.
See how it works →
Who we work with
The teams our reporting reaches
Insights are delivered in de-identified, aggregate form. They show where clinical questions remain unanswered, and because nothing is attributed to an individual, clinicians speak openly.
Regional Marketing
Thought Leader Liaisons
Medical Science Liaisons
Commercial Leadership
Clinical Development
What our programs explore
The questions that keep coming up
Gynecologic oncology is all we do. We are at SGO, ASCO, ESMO, ESGO, IGCS, and regional society meetings, tracking data and sentiment as it lands. Our programs are designed to understand key areas of care:
Treatment approaches across gynecologic and medical oncologists
Management in university versus community settings
How responsibilities divide across the broader care team
Emerging data that shifts practice before the guidelines do
Sequencing decisions among approved agents
Biomarker-directed versus all-comers strategies
Real-world toxicity and the barriers it creates for patients
Regional variation in patient management
And so much more…
By the numbers
Two years of gynecologic oncology, by the numbers.
The scope of our work and the network behind it, in one place.
